Stability Studies and Release Testing

Stability Studies and Release Testing

Products
Stability Studies and Release Testing
Stability Studies and Release Testing
Stability Studies and Release Testing

Information

Coriolis Pharma offers comprehensive GMP and non-GMP analyses for the release and stability testing of biopharmaceutical products – from early development stages through to commercial production. This includes ICH-compliant stability studies under controlled climate and storage conditions to ensure product efficacy, quality, and safety throughout its shelf life . The portfolio is complemented by robust release testing to verify compliance with the Target Product Profile (TPP) and regulatory requirements.
All Categories
PeptidesBiopharmaceuticals (General Category)BiosimilarsStability TestingAntibodiesMonoclonal AntibodiesCell & Gene therapyAntiinfectives for Systemic use
Main Categories
Biopharmaceutical ProductsInnovative APIsLaboratory and Analytical ServicesAnatomical Therapeutic Chemical (ATC) Classification Products
Coriolis Pharma Research GmbHCoriolis Pharma is a globally operating contract research and development organization (CRDO) and the premier partner for drug product development, analytical, and manufacturing services across a vast array of therapeutic modalities, including antibodies, peptides, therapeutic proteins, cell and gene therapy, nucleic acids and more. We focus on liquid and lyophilized drug products and provide our services under both, R&D and GMP conditions. Our expert scientists design and execute our platform and custom services to accelerate and derisk your path to market.

Log in

See all the content and easy-to-use features by logging in or registering!